Roche NimbleGen
Products and services to the life science research market.
Launch date
Employees
Market cap
-
Enterprise valuation
$33—49m (Dealroom.co estimates Dec 2005.)
Madison Wisconsin (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$10.5m | Series B | ||
$12.5m | Series D | ||
$12.8m | Series F | ||
N/A | $8.2m | Series F | |
N/A | N/A | Acquisition | |
Total Funding | $44.0m |